Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Thrombophilia in ischemic stroke.

× No keyword cloud information.

9 in total

Review 1. Risk factors for venous thrombosis: prevalence, risk, and interaction.

Authors: F R Rosendaal
Journal: Semin Hematol Date: 1997-07 Impact factor: 3.851

Review 2. Hematologic disorders and ischemic stroke. A selective review.

Authors: R G Hart; M C Kanter
Journal: Stroke Date: 1990-08 Impact factor: 7.914

3. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis.

Authors: S Cortelazzo; G Finazzi; M Ruggeri; O Vestri; M Galli; F Rodeghiero; T Barbui
Journal: N Engl J Med Date: 1995-04-27 Impact factor: 91.245

4. High plasma levels of plasminogen activator inhibitor 1 (PAI-1) in polycythemia vera and essential thrombocythemia are associated with thrombosis.

Authors: J A Cancelas; A García-Avello; L J García-Frade
Journal: Thromb Res Date: 1994-09-01 Impact factor: 3.944

5. Hypercoagulability in acute stroke: prognostic significance.

Authors: G Landi; A D'Angelo; E Boccardi; L Candelise; P M Mannucci; E Nobile Orazio; A Morabito
Journal: Neurology Date: 1987-10 Impact factor: 9.910

6. Reduction of antithrombin III, protein C, and protein S levels and activated protein C resistance in polycythemia vera and essential thrombocythemia patients with thrombosis.

Authors: A Bucalossi; G Marotta; C Bigazzi; P Galieni; E Dispensa
Journal: Am J Hematol Date: 1996-05 Impact factor: 10.047

Thrombophilia in ischemic stroke.

Review 1. Risk factors for venous thrombosis: prevalence, risk, and interaction.

Review 2. Hematologic disorders and ischemic stroke. A selective review.

3. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis.

4. High plasma levels of plasminogen activator inhibitor 1 (PAI-1) in polycythemia vera and essential thrombocythemia are associated with thrombosis.

5. Hypercoagulability in acute stroke: prognostic significance.

6. Reduction of antithrombin III, protein C, and protein S levels and activated protein C resistance in polycythemia vera and essential thrombocythemia patients with thrombosis.

Review 7. Risk factors and outcomes for ischemic stroke.

8. Low proteins C and S and activation of fibrinolysis in treated essential thrombocythemia.

9. Ischemic stroke as first manifestation of essential thrombocythemia. Report of six cases.